These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659 [TBL] [Abstract][Full Text] [Related]
3. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction. Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480 [TBL] [Abstract][Full Text] [Related]
6. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429 [TBL] [Abstract][Full Text] [Related]
7. Chronic lung allograft dysfunction after lung transplantation: the moving target. Sato M Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970 [TBL] [Abstract][Full Text] [Related]
8. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival. Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181 [TBL] [Abstract][Full Text] [Related]
9. Validation of a post-transplant chronic lung allograft dysfunction classification system. Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199 [TBL] [Abstract][Full Text] [Related]
10. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival. Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624 [TBL] [Abstract][Full Text] [Related]
11. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation. Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267 [TBL] [Abstract][Full Text] [Related]
12. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction. Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441 [TBL] [Abstract][Full Text] [Related]
13. Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation. Sato M; Hwang DM; Ohmori-Matsuda K; Chaparro C; Waddell TK; Singer LG; Hutcheon MA; Keshavjee S J Heart Lung Transplant; 2012 Apr; 31(4):354-63. PubMed ID: 22330935 [TBL] [Abstract][Full Text] [Related]